Abbott Laboratories $5.8 billion acquisition of Alere

1/2/2016
Public acquisition

$ 5.8 billion

Completed

1/2/2016


Overview:

  • Abbott Laboratories has acquired Alere in a $5.8 billion deal.
  • Alere produces infection tests for HIV, tuberculosis, and other communicable diseases.
  • Alere's $2.6 billion net debt will be assumed or refinanced by Abbott.
  • Evercore was financial adviser to Abbott.
  • Kirkland & Ellis (Daniel Wolf, David Feirstein, Laura Sullivan, John Kupiec) advised Abbott.
  • Cravath Swaine & Moore (Scott Barshay, Keith Hallam) represented Alere.
  • Wilson Sonsini Goodrich & Rosati (Larry Sonsini, Bradley Finkelstein, Jamillia Ferris, Douglas Schnell) advised Evercore.

Kurt Stumpo - Journalist - North America and the Caribbean

Jurisdiction:

United States

Deal type:

Public acquisition

Practice area:

M&A

Governing law:

United States

Industry sector:

Pharmaceuticals and life sciences


Firms:

Party: Alere (Target)


Party: Abbott Laboratories (Acquirer)

Lawyer: Daniel Wolf


Party: Evercore (Financial adviser)